Enisamium iodide
依尼碘铵
Report date: 2026/03/26 20:00:17
NME
Base Information
Drug NameEnisamium iodide
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2011/02/16
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesFarmak As
China Registration ClassN/A
Develop Information
Active CompaniesJoint Stock Company FarmakFarmak As
Inactive CompaniesN/A
Active Indications
Inactive Indications
Other Information
ATC Code
Related LinksN/A